Detalhe da pesquisa
1.
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
Nature
; 588(7836): 157-163, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33239784
2.
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST).
Int J Mol Sci
; 24(6)2023 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36982486
3.
Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.
Transfus Apher Sci
; 60(5): 103197, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175195
4.
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis.
Eur J Haematol
; 104(2): 125-137, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31758597
5.
Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST).
Int J Cancer
; 145(8): 2292-2303, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30882891
6.
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Eur J Haematol
; 102(5): 437-441, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30725494
7.
Transcriptomic profiling does not refine mastocytosis diagnosis
Haematologica
; 108(11): 3125-3130, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165843
8.
Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies.
J Cancer Res Clin Oncol
; 148(2): 331-340, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34654952
9.
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML.
Cancer Res
; 80(11): 2394-2406, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32041835
10.
Correction: Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study.
Leukemia
; 34(11): 3106, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651539
11.
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose.
Exp Hematol Oncol
; 8: 9, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31016067
12.
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile.
Oncotarget
; 9(25): 17270-17281, 2018 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29707107
13.
Elevated RIPK3 correlates with disease burden in myelofibrosis.
Blood Adv
; 7(7): 1219-1224, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453650
14.
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells.
Cancer Cell
; 30(1): 75-91, 2016 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27411587
15.
How do Supervising Clinicians of a University Hospital and Associated Teaching Hospitals Rate the Relevance of the Key Competencies within the CanMEDS Roles Framework in Respect to Teaching in Clinical Clerkships?
GMS Z Med Ausbild
; 32(3): Doc33, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26413171
16.
Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study.
Leukemia
; 34(7): 1949-1953, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32474573
17.
Everolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study.
Leuk Lymphoma
; 56(11): 3227-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25754578